Patents by Inventor Lawrence M. Steinman

Lawrence M. Steinman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis
    Patent number: 9140701
    Abstract: Compositions and methods are provided for prognostic classification of rheumatoid arthritis disease patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: September 22, 2015
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: William H. Robinson, Peggy Pui-Kay Ho, Xiaoyan Zhao, Lawrence M. Steinman
  • Proteomic analysis of active multiple sclerosis lesions
    Patent number: 8257700
    Abstract: The invention provides methods for treating demyelinating inflammatory diseases by administering to the subject an effective amount of an agent that provides activated protein C activity, where the dose is effective to reduce the adverse clinical indicia of the disease. In some embodiments, the patient being treating is of the chronic active plaque type.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: September 4, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lawrence M. Steinman, May H. Han
  • Fibrinogen immune complexes to diagnose and guide therapy in rheumatoid arthritis
    Publication number: 20110047632
    Abstract: Compositions and methods are provided for prognostic classification of rheumatoid arthritis disease patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest.
    Type: Application
    Filed: August 4, 2010
    Publication date: February 24, 2011
    Inventors: William H. Robinson, Peggy Pui-Kay Ho, Xiaoyan Zhao, Lawrence M. Steinman
  • Proteomic analysis of active multiple sclerosis lesions
    Publication number: 20090208481
    Abstract: The invention provides methods for treating demyelinating inflammatory diseases by administering to the subject an effective amount of an agent that provides activated protein C activity, where the dose is effective to reduce the adverse clinical indicia of the disease. In some embodiments, the patient being treating is of the chronic active plaque type.
    Type: Application
    Filed: February 5, 2009
    Publication date: August 20, 2009
    Inventors: Lawrence M. Steinman, May H. Han